Dec 5 (Reuters) - Novartis Ag NOVN.S :
* NOVARTIS PHARMACEUTICALS CANADA - RYDAPT (MIDOSTAURIN) HAS BEEN APPROVED FOLLOWING A PRIORITY REVIEW BY HEALTH CANADA
Dec 5 (Reuters) - Novartis Ag NOVN.S :
* NOVARTIS PHARMACEUTICALS CANADA - RYDAPT (MIDOSTAURIN) HAS BEEN APPROVED FOLLOWING A PRIORITY REVIEW BY HEALTH CANADA